Laboratory

Disease Detection

Infectious Disease Detection

SARS-CoV-2 & Influenza A/B Antigen Combo Rapid Test Kit

Antigen Rapid Test Kit (LFIA)

DaAn_Monkeypox_single.jpg
DaAn_Monkeypox_single.jpg

Available for pre-order

Designed for rapid detection of SARS-CoV-2, Influenza A or B

About this kit

SARS-Cov-2 Influenza A/B Antigen Combo Rapid Test Kit (LFIA) is an immunochromatography based, one-step invitro test designed for the rapid qualitative determination of the above virus antigens in anterior nasal swabs from individuals suspected of COVID-19, Influenza A and Influenza B within the first seven days of symptom onset*. The test kit is designed for use as self-testing. 


*Note that the combo rapid test kit shall not be used as sole basis to diagnose or exclude SARS-Cov-2 Influenza A/B infection.



Please contact us at sales@invitrovista.com for enquiries and immediate dispatch from Sweden.

Specifications


Test Principle

Colloidal Gold Immunochromatography
 

Specimen Type

Anterior Nasal Swab
 

Storage and Shelf Life

Storage away from direct sunlight, 2-30℃
Test kit must be used within 1 hour of opening foil pouch
 

Certificate

CE IVD

Features


Convenience
Easily detect the presence of SARS-CoV-2, Influenza A or Influenza B antigens in one easy-to-use kit
 

Order Information


Manufacturer

Medomics
 

Tests per kit

1
 

Previous
Next